QTREX Quantum (NASDAQ:QTEX) Shares Cross Above 50 Day Moving Average – Time to Sell?

Shares of QTREX Quantum Ltd. (NASDAQ:QTEX) crossed above its 50 day moving average during trading on Thursday. The stock has a 50 day moving average of $1.13 and traded as high as $1.1950. QTREX Quantum shares last traded at $1.19, with a volume of 6,584,214 shares.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the company. Wall Street Zen cut QTREX Quantum from a “hold” rating to a “sell” rating in a research report on Saturday, August 8th. Weiss Ratings lowered shares of QTREX Quantum from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday, October 9th. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat, QTREX Quantum currently has a consensus rating of “Sell”.

QTREX Quantum Price Performance

The business has a fifty day simple moving average of $1.13. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.62 and a current ratio of 2.00.

QTREX Quantum (NASDAQ:QTEX) last announced its quarterly earnings results on Thursday, September 24th. The company reported ($0.07) earnings per share (EPS) for the quarter. The company had revenue of $0.78 million for the quarter.

Insider Activity

In other news, CEO Dagi Ben-Noon bought 168,894 shares of the firm’s stock in a transaction dated Monday, September 28th. The stock was purchased at an average price of $0.71 per share, with a total value of $119,914.74. Following the transaction, the chief executive officer owned 3,646,133 shares of the company’s stock, valued at approximately $2,588,754.43. The trade was a 4.86% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Over the last three months, insiders purchased 207,834 shares of company stock valued at $181,275. 29.40% of the stock is currently owned by corporate insiders.

QTREX Quantum Company Profile

Inspira Technologies OXY B.H.N. Ltd. is a medical technology company focused on developing advanced respiratory-support and blood-monitoring solutions for critical-care settings. The company’s technologies are intended to help address complications associated with respiratory failure and improve the management of patients requiring oxygenation support. Its product portfolio includes the INSPIRA ART system, an extracorporeal respiratory-support platform designed to provide oxygenation while potentially reducing the need for conventional mechanical ventilation or more complex extracorporeal membrane oxygenation procedures.